REGISTERED AND RENEWED
on 12 Sep 2024
Last Applicant/ Owned by
VOLMERSTRASSE 5 (UTZ)
Berlin
DE
12489
Serial Number
76434604 filed on 25th Jul 2002
Registration Number
2868416 registered on 03rd Aug 2004
Correspondent Address
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
10th Floor
Washington, DC 20005
United States
Filing Basis
1. intent to use
Disclaimer
NO DATA
PEPSTAR
[ Scientific research, namely, immobilization of arrays of chemical compounds, modification of peptides and proteins, transformation of chemical compounds; scientific and technological services and research as well as designer services for third parties in the field of biotechnology and pharmaceuticals, namely, development of new technology for others; design and development of new technology for Read More
Classification Information
Class [010]
Medical Instrument Products
[ Analytical device, namely, nanoplotter for medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
[ Scientific measuring and checking apparatus and instruments, namely, micro-array scanner comprised of filters and cellulose or polypropylene membranes for use in the field of biotechnology, pharmacology and for use in pharmaceutical research; analytical device, namely, robot, synthesizer, spotter and nanoplotter for non-medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
[ Human and veterinary pharmaceutical preparations for the treatment of illnesses caused by defects in signal transduction cascades, namely, cancer, neurodegenerative diseases, allergic diseases and cardiovascular diseases, comprised of amino acids, nucleic acids, peptides, proteins, and peptidomimetics; carrier materials comprised of [ nucleic acids, peptides and proteins for diagnostic purposes for medical treatments ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
[ Chemicals for use in the manufacture of pharmaceuticals; ] carrier materials comprised of [ nucleic acids, ] peptides and proteins for research purposes, for pharmaceutical research, for diagnostic purposes for scientific research, for biochemical research purposes in the field of antibody epitope mapping, proteine/proteine interaction, and enzyme profiling
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [044]
Medical, Beauty & Agricultural Services
[ Human and veterinary medical services; pharmaceutical advice; physician services; veterinary services ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
[ Scientific research, namely, immobilization of arrays of chemical compounds, modification of peptides and proteins, transformation of chemical compounds; scientific and technological services and research as well as designer services for third parties in the field of biotechnology and pharmaceuticals, namely, development of new technology for others; design and development of new technology for others in the field of biotechnology and pharmaceuticals; industrial analysis and research services in the field of biotechnology and pharmaceuticals, namely, synthesis and immobilization of chemicals used in industry and science, screening for interaction partners, antibody epitope mapping, proteine/proteine interaction, and enzyme profiling; design and development of computer hardware and software; scientific research in the field of synthesis and immobilization of chemicals use in industry and science; chemical research, namely, screening for chemical interactions of enzymes, enzyme substrates, antigens and antibodies; development of inhibitors of receptors and enzymes, namely, kinases, oxydoreductases, transerases, hydrolases, lyases, isomerases, and ligases; research and development of diagnostic assays, assays for pharmaceutical drug discovery and assays for target validation, namely, methods for antigene detection and enzyme substrate identification for others; product research and development of chemicals used in industry and science; computer programming for other for the herein aforementioned purposes; agricultural research; scientific research; industrial design; computer programming for others; chemist, biologist, biochemist, biotechnologist, gene technologist, molecular biologist, pharmacology, and physicist services ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
[ Custom synthesis of chemicals used in industry and science for third parties; custom immobilization of arrays of chemicals compounds for others, custom modification of peptides and proteins for others and custom transformation of chemical compounds for others]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 76434604
Mark Type
No Service Mark
Attorney Docket Number
No 3814.0510000
44D Filed
Yes
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Sep 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 12th Sep 2024 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
| 12th Sep 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 10th Sep 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 26th Jun 2024 | TEAS SECTION 8 & 9 RECEIVED |
| 27th Sep 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 27th Sep 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 27th Sep 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 27th Sep 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 27th Sep 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |